Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Polish
  • Turkish

Breadcrumb

  1. Home
  2. Chronical inflammatory bowel diseases (IBD)
  3. Role of the intestinal epithelium and the innate immune response
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Chronical inflammatory bowel diseases (IBD)
  3. Role of the intestinal epithelium and the innate immune response
Gastroenterology

Role of the intestinal epithelium and the innate immune response

IBD
Gastroenterology

The dysbiosis observed in IBD could be related to an alteration of the gut epithelium, which is no longer able to play its barrier role, as well as to a dysregulation of the local innate immune response that promotes inflammation. Explanations and focus on antimicrobial peptides.

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Sections

Rôle de l’épithélium intestinal image

Intestinal epithelium

About this article

Created 17 September 2019
Updated 15 July 2024

The alteration of the intestinal barrier observed in patients with IBD could explain the pathophysiology of dysbiosis: not only would this mechanical frontier be altered, but also its first line of immune defense.

Besides its role in the absorption of ions, water and other nutrients, the intestinal barrier serves as a wall and prevents the entry of bacteria into the gut lumen. But its permeability increases in acute phases of Crohn’s disease (CD), which promotes translocation of bacteria through the mucus as well as local inflammation.5

The role of the instestinal barrier

Potential causes: alteration of the tight junctions of intestinal epithelial cadherins (glycoproteins playing a key role in intracellular adherence); involvement of some transcription factors11 related to epithelial regeneration. Other mechanisms under discussion involve the gut mucus, whose thickness keeps pathogenic bacteria at bay, but which is considerably decreased in patients with IBD. This phenomenon could be explained by the alteration of mucus- producing goblet cells whose disruption induces the development of colitis in murine models. It could also be explained in patients with CD by the impairment of Paneth cells located at the bottom of small intestinal crypts, known to be involved in homeostasis and with a defensive role of the gut mucus through antimicrobial secretion.5,11

First line of defense of the immune system

The scientific literature also mentions several mechanisms involving innate immunity, and more precisely dendritic cells, macrophages, innate lymphoid cells and neutrophils. These cells, which complete the previously described system, act as the first line of defense of the immune system. In the intestines of healthy subjects, macrophages are hyporeactive (reduced proliferation and activity) and can produce anti-inflammatory cytokines.11 On the contrary, in patients with IBD, the imbalance in innate immunity cell populations could be associated to several phenomena:11 bacteria crossing the mucus which became permeable due to macrophage activity decrease and defective neutrophil recruitment; inflammation induced by the production of large quantities of pro-inflammatory cytokines (TNF-α and IL-6) by specific macrophages; and inflammatory T-cell recruitment through the accumulation of dendritic cells which induce an adaptive immune response.

Image
Role of the intestinal epithelium infography
Image
Focus on the role of antimicrobial peptides
Sources

11 Ramos GP, Papadakis KA. Mechanisms of Disease: Inflammatory Bowel Diseases. Mayo Clin Proc. 2019;94(1):155-165.

Tags
Dysbiosis Gut health Immune response Microbiome Flora
    Focus
    Chronical inflammatory bowel diseases (IBD)
    • Dysbiosis in IBD
      • A bacterial dysbiosis characteristic of IBD
      • Each IBD has its own virome
      • Association between fungal dysbiosis and environment
    • Pathophysiology of dysbiosis
      • Role of the intestinal epithelium and the innate immune response
      • Focus on the role of antimicrobial peptides
    • What role could microbiota modulation play?
      • Fecal microbiota transplant: mixed results
      • Use of probiotics
    • Expert opinion
      • Pr. Philippe Seksik: Towards an innovative management of IBD
    Created 17 September 2019
    Updated 15 July 2024

    About this article

    To know more about this topic.

    Main topic

    IBD

    Medical practice

    Gastroenterology

    Content type

    Dossier detail
    Association between fungal dysbiosis and environment
    Focus on the role of antimicrobial peptides
    Focus

    Chronical inflammatory bowel diseases (IBD)

    Dysbiosis in IBD

    A bacterial dysbiosis characteristic of IBD Each IBD has its own virome Association between fungal dysbiosis and environment

    Pathophysiology of dysbiosis

    Role of the intestinal epithelium and the innate immune response Focus on the role of antimicrobial peptides

    What role could microbiota modulation play?

    Fecal microbiota transplant: mixed results Use of probiotics

    Expert opinion

    Pr. Philippe Seksik: Towards an innovative management of IBD
    Gastroenterology
    Actu PRO : Malnutrition : agir sur le microbiote pour améliorer la croissance, un prototype à l’essai
    08.07.2021

    Malnutrition: acting on the microbiota in order to improve growth, a trial prototype

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    07.02.2025

    Your functional dyspepsia diagnosis check list

    Read the article
    17.04.2025

    Sensitivity to the additive E466: the role of the microbiota

    Read the article
    Photo HCPs: Clinical context over quick fix: the fresh consensus on microbiome testing
    11.04.2025

    Clinical context over quick fix: the fresh consensus on microbiome testing

    Read the article
    22.11.2023

    Is vaginal microbiota transfer the new miracle for C-section babies?

    Read the article
    Actu PRO : Alcoolisme : expliquer les troubles sociaux grâce au microbiote
    27.01.2021

    Alcoholism: explaining social disorders thanks to the microbiota

    Read the article

    Association between fungal dysbiosis and environment

    The fungal portion of the gut microbiota (or mycobiota) has been much less studied than the bacterial...

    Find out more
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Russian
    • Polish
    • Turkish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    02.05.2025

    A new lens on chlamydia: beyond behavior, into the microbiome

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo